| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | Aug 4, 2020 | Adaptimmune Therapeutics PLC | Chief Business Officer | Sell | 5.0 | -200,000 | -100.00% | ✓ | $1.7M |
| Jan 13, 2020 | Jan 15, 2020 | Adaptimmune Therapeutics PLC | Chief Business Officer | Sell | 7.5 | -100,000 | -100.00% | ✓ | $450K |